Monoclonal antibodies targeting VEGF in ophtalmology: The case of exudative age-related macular degeneration;Anti-VEGF: Applications pratiques en ophtalmologie

Medecine/Sciences

Volumn 25, Issue 12, 2009, Pages 1105-1107

  Leveziel, Nicolas ^a   Soubrane, Gisèle ^a   Souied, Eric H ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 74749104228     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200925121105     Document Type: Review

References (5)

1. Leveziel N, Delcourt C, Zerbib J, et al. Epidemiology of age related macular degeneration. J Fr Ophtalmol 2009 ; 32 : 440-51.
2. Bressler NM. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 2009 ; 116 : 15-23.
3. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration : a review of progress to date. Surv Ophthalmol 2006 ; 51 : 316-63.
4. Behar-Cohen F, Sennlaub F, Berdugo M. Age-related macular degeneration : therapeutic hopes. Med Sci (Paris) 2007 ; 23 : 127-9.
5. Nguyen QD, Shah SM, Browning DJ, et al. A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. Ophthalmology 2009 (sous presse).